Preface |
|
vii | |
|
|
1 | (46) |
|
|
1 | (15) |
|
|
16 | (10) |
|
|
26 | (9) |
|
|
35 | (6) |
|
|
41 | (6) |
|
|
47 | (46) |
|
6 Introduction to Autonomic Pharmacology |
|
|
47 | (13) |
|
7 Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs |
|
|
60 | (9) |
|
8 Cholinoceptor Blockers 8c Cholinesterase Regenerators |
|
|
69 | (7) |
|
|
76 | (9) |
|
|
85 | (8) |
|
PART III CARDIOVASCULAR DRUGS |
|
|
93 | (52) |
|
11 Drugs Used in Hypertension |
|
|
93 | (10) |
|
12 Drugs Used in the Treatment of Angina Pectoris |
|
|
103 | (9) |
|
13 Drugs Used in Heart Failure |
|
|
112 | (10) |
|
|
122 | (12) |
|
15 Diuretics & Other Drugs That Act on the Kidney |
|
|
134 | (11) |
|
PART IV DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE |
|
|
145 | (38) |
|
16 Histamine, Serotonin, Drugs Used in Obesity, Ergot Alkaloids, & Other Drugs Used in Migraine |
|
|
145 | (10) |
|
|
155 | (7) |
|
18 Prostaglandins & Other Eicosanoids |
|
|
162 | (7) |
|
19 Nitric Oxide, Donors, & Inhibitors |
|
|
169 | (4) |
|
20 Drugs Used in Asthma & Chronic Obstructive Pulmonary Disease |
|
|
173 | (10) |
|
PART V DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM |
|
|
183 | (94) |
|
21 Introduction to CNS Pharmacology |
|
|
183 | (7) |
|
22 Sedative-Hypnotic Drugs |
|
|
190 | (8) |
|
|
198 | (7) |
|
|
205 | (9) |
|
|
214 | (8) |
|
|
222 | (5) |
|
27 Skeletal Muscle Relaxants |
|
|
227 | (8) |
|
28 Drugs Used in Parkinsonism & Other Movement Disorders |
|
|
235 | (8) |
|
29 Antipsychotic & Bipolar Disorder Agents |
|
|
243 | (9) |
|
|
252 | (8) |
|
31 Opioid Analgesics & Antagonists |
|
|
260 | (9) |
|
|
269 | (8) |
|
PART VI DRUGS WITH IMPORTANT ACTIONS ON BLOOD, INFLAMMATION, & GOUT |
|
|
277 | (42) |
|
33 Agents Used in Cytopenias; Hematopoietic Growth Factors |
|
|
277 | (9) |
|
34 Drugs Used in Coagulation Disorders |
|
|
286 | (12) |
|
35 Agents Used in Dyslipidemia |
|
|
298 | (9) |
|
36 NSAIDs, Acetaminophen, & Drugs Used in Rheumatoid Arthritis & Gout |
|
|
307 | (12) |
|
|
319 | (52) |
|
37 Hypothalamic & Pituitary Hormones |
|
|
319 | (9) |
|
38 Thyroid & Antithyroid Drugs |
|
|
328 | (6) |
|
39 Adrenocorticosteroids & Adrenocortical Antagonists |
|
|
334 | (7) |
|
40 Gonadal Hormones & Inhibitors |
|
|
341 | (11) |
|
41 Pancreatic Hormones, Antidiabetic Drugs, & Glucagon |
|
|
352 | (10) |
|
42 Agents That Affect Bone Mineral Homeostasis |
|
|
362 | (9) |
|
PART VIII CHEMOTHERAPEUTIC DRUGS |
|
|
371 | (110) |
|
43 Beta-Lactam Antibiotics & Other Cell Wall & Membrane-Active Antibiotics |
|
|
372 | (9) |
|
44 Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones |
|
|
381 | (8) |
|
45 Aminoglycosides & Spectinomycin |
|
|
389 | (5) |
|
46 Sulfonamides, Trimethoprim, & Fluoroquinolones |
|
|
394 | (7) |
|
47 Antimycobacterial Drugs |
|
|
401 | (7) |
|
|
408 | (7) |
|
|
415 | (13) |
|
50 Miscellaneous Antimicrobial Agents & Disinfectants, Antiseptics, & Sterilants |
|
|
428 | (6) |
|
51 Clinical Use of Antimicrobial Agents |
|
|
434 | (6) |
|
|
440 | (9) |
|
53 Clinical Pharmacology of the Antihelminthic Drugs |
|
|
449 | (6) |
|
|
455 | (12) |
|
|
467 | (14) |
|
|
481 | (20) |
|
56 Environmental & Occupational Toxicology |
|
|
481 | (6) |
|
57 Heavy Metals & Chelators |
|
|
487 | (6) |
|
58 Management of the Poisoned Patient |
|
|
493 | (8) |
|
|
501 | (24) |
|
59 Drugs Used in Gastrointestinal Disorders |
|
|
501 | (10) |
|
|
511 | (3) |
|
61 Dietary Supplements & Herbal Medications |
|
|
514 | (5) |
|
62 Important Drug Interactions & Their Mechanisms |
|
|
519 | (6) |
Appendix I Strategies for Improving Test Performance |
|
525 | (3) |
Appendix II Key Words for Key Drugs |
|
528 | (14) |
Appendix III Examination 1 |
|
542 | (16) |
Appendix IV Examination 2 |
|
558 | (15) |
Index |
|
573 | |